Literature DB >> 15537850

Methadone: applied pharmacology and use as adjunctive treatment in chronic pain.

R Brown1, C Kraus, M Fleming, S Reddy.   

Abstract

This article reviews the unique pharmacological properties of methadone and outlines its appropriate clinical application, with focus upon its use in the treatment of chronic pain. Although methadone is most widely known for its use in the treatment of opioid dependence, methadone also provides effective analgesia. Patients who experience inadequate pain relief or intolerable side effects with other opioids or who suffer from neuropathic pain may benefit from a transition to methadone as their analgesic agent. Adverse effects, particularly respiratory depression and death, make a fundamental knowledge of methadone's pharmacological properties essential to the provider considering methadone as analgesic therapy for a patient with chronic pain.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15537850      PMCID: PMC1743125          DOI: 10.1136/pgmj.2004.022988

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  54 in total

1.  Pharmacokinetic interactions of nevirapine and methadone and guidelines for use of nevirapine to treat injection drug users.

Authors:  S M Clarke; F M Mulcahy; J Tjia; H E Reynolds; S E Gibbons; M G Barry; D J Back
Journal:  Clin Infect Dis       Date:  2001-09-24       Impact factor: 9.079

Review 2.  HIV drug interactions: the good, the bad, and the other.

Authors:  Petrie M Rainey
Journal:  Ther Drug Monit       Date:  2002-02       Impact factor: 3.681

Review 3.  Therapeutic drug monitoring in methadone maintenance: choosing a matrix.

Authors:  E T Moolchan; A Umbricht; D Epstein
Journal:  J Addict Dis       Date:  2001

Review 4.  Drug interactions with patient-controlled analgesia.

Authors:  Jorn Lotsch; Carsten Skarke; Irmgard Tegeder; Gerd Geisslinger
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

5.  Paroxetine increases steady-state concentrations of (R)-methadone in CYP2D6 extensive but not poor metabolizers.

Authors:  Stefan Begré; Ulrich von Bardeleben; Dieter Ladewig; Sylvie Jaquet-Rochat; Line Cosendai-Savary; Kerry Powell Golay; Markus Kosel; Pierre Baumann; Chin B Eap
Journal:  J Clin Psychopharmacol       Date:  2002-04       Impact factor: 3.153

6.  Effect of ritonavir/saquinavir on stereoselective pharmacokinetics of methadone: results of AIDS Clinical Trials Group (ACTG) 401.

Authors:  J G Gerber; S Rosenkranz; Y Segal; J Aberg; R D'Amico; D Mildvan; R Gulick; V Hughes; C Flexner; F Aweeka; A Hsu; J Gal
Journal:  J Acquir Immune Defic Syndr       Date:  2001-06-01       Impact factor: 3.731

7.  Methadone blood concentrations are decreased by the administration of abacavir plus amprenavir.

Authors:  P A Bart; P G Rizzardi; S Gallant; K P Golay; P Baumann; G Pantaleo; C B Eap
Journal:  Ther Drug Monit       Date:  2001-10       Impact factor: 3.681

Review 8.  Cognitive-motor performance of methadone-maintained patients.

Authors:  M Specka; T Finkbeiner; E Lodemann; K Leifert; J Kluwig; M Gastpar
Journal:  Eur Addict Res       Date:  2000-03       Impact factor: 3.015

Review 9.  The use of methadone for cancer pain.

Authors:  Carla Ripamonti; Mauro Bianchi
Journal:  Hematol Oncol Clin North Am       Date:  2002-06       Impact factor: 3.722

10.  Gonadal function in male heroin and methadone addicts.

Authors:  G Ragni; L De Lauretis; O Bestetti; D Sghedoni; V Gambaro
Journal:  Int J Androl       Date:  1988-04
View more
  22 in total

1.  Applying legal risk management to the clinical use of methadone.

Authors:  James O'Donnell; F Randy Vogenberg
Journal:  P T       Date:  2011-12

2.  Electrocardiogram Abnormality Associated with Methadone Overdose.

Authors:  Mahsa Agahi; Vahid Shakoori; Sayed Mahdi Marashi
Journal:  Sultan Qaboos Univ Med J       Date:  2016-02-02

Review 3.  Therapeutic approaches for neonatal abstinence syndrome: a systematic review of randomized clinical trials.

Authors:  Masumeh Ghazanfarpour; Mona Najaf Najafi; Nasibeh Roozbeh; Mohamadghasem Etemadi Mashhadi; Atefeh Keramat-Roudi; Bruno Mégarbane; Aristidis Tsatsakis; Mohammad Mobin Miri Moghaddam; Ramin Rezaee
Journal:  Daru       Date:  2019-05-15       Impact factor: 3.117

4.  [Accidental levomethadone intoxication in a palliative patient].

Authors:  B Michel-Lauter; C Maier; A Schwarzer
Journal:  Schmerz       Date:  2012-12       Impact factor: 1.107

Review 5.  Methadone: a new old drug with promises and pitfalls.

Authors:  Jodie A Trafton; Abhinav Ramani
Journal:  Curr Pain Headache Rep       Date:  2009-02

6.  Methadone Use and the Risk of Hypoglycemia for Inpatients With Cancer Pain.

Authors:  James H Flory; Alison C Wiesenthal; Howard T Thaler; Lauren Koranteng; Natalie Moryl
Journal:  J Pain Symptom Manage       Date:  2015-09-03       Impact factor: 3.612

7.  Drug-induced torsades de pointes in an underserved urban population. Methadone: is there therapeutic equipoise?

Authors:  Jorge Romero; Samuel H Baldinger; David Goodman-Meza; Krysthel Engstrom; Carolina R Valencia; Anjani Golive; Francisco Medrano; Sabarivinoth Rangasamy; Mohammed Makkiya; John D Fisher; Jay Gross; Andrew Krumerman; Soo Kim; Mario J Garcia; Luigi Di Biase; Kevin J Ferrick
Journal:  J Interv Card Electrophysiol       Date:  2015-11-20       Impact factor: 1.900

Review 8.  The anti-addiction drug ibogaine and the heart: a delicate relation.

Authors:  Xaver Koenig; Karlheinz Hilber
Journal:  Molecules       Date:  2015-01-29       Impact factor: 4.411

9.  Chronic opioid use modulates human enteric microbiota and intestinal barrier integrity.

Authors:  Angélica Cruz-Lebrón; Ramona Johnson; Claire Mazahery; Zach Troyer; Samira Joussef-Piña; Miguel E Quiñones-Mateu; Christopher M Strauch; Stanley L Hazen; Alan D Levine
Journal:  Gut Microbes       Date:  2021 Jan-Dec

10.  Trazodone in methandone induced erectile dysfunction.

Authors:  Faezeh Tatari; Vahid Farnia; Reza Faghih Nasiri; Farid Najafi
Journal:  Iran J Psychiatry       Date:  2010
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.